MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202617072054 A) filed by Les Laboratoires Servier; and Novartis AG on June 10, 2026, for Anti-Cd7 Antibody-Drug Conjugates And Methods Of Use Thereof.
Inventors include Burger, Matthew Terrence; D'Alessio, Joseph Anthony; Mcneill, Eric Andrew; Nakajima, Katsumasa; Newcombe, Richard Vaughan; Yu, Bing; Zhang, Qiang; Hollingworth, Gregory, John Number; Langlois, Jean-Baptiste Georges Armand; Maragno, Ana Leticia; Starck, Jrme-Benot; Bresson, Laura; Braizat, Gatane; Fejes, Imre; Szlvik, Zoltn; Ray, Stuart; and Chen, Zhuoliang.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: Antibody-drug conjugates that bind to human oncology targets are disclosed. The antibody-drug conjugates comprise an antibody or an antigen-binding fragment thereof covalently linked to at least one BH3 mimetic through a dual linker and the antigen-binding fragment thereof binds to target antigen CD7. The disclosure further relates to methods and compositions for use in the treatment of cancers by administering the antibody-drug conjugates provided herein. Linker-drug conjugates comprising at least one BH3 mimetic and methods of making the same are also disclosed.
Disclaimer: Curated by HT Syndication.
